title: Cav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation.
abstract: Caveolin-1 (Cav1) is the main protein component of the membrane lipid rafts caveolae. Cav1 serves as a scaffolding protein that compartmentalizes a multitude of signaling molecules and sequesters them in their inactive state. Due to its function in the negative regulation of signal transduction, loss of Cav1 has been implicated in the pathogenesis of many cancers, but its role in cutaneous squamous cell carcinoma (cSCC) is largely unexplored. cSCC is a multi-stage disease characterized by the development of benign, premalignant lesions and their progression into malignant cancer. Here, we use a two-stage carcinogenesis protocol to elucidate the function of Cav1 in the different stages of benign papilloma development: initiation and promotion. First, we demonstrate that Cav1 knock-out (KO) mice are more susceptible to benign papilloma development after being subjected to a DMBA/TPA initiation/promotion protocol. Treatment of wild-type (WT) and Cav1 KO mice with DMBA alone shows that both groups have similar rates of apoptosis. In contrast, treatment of these groups with TPA alone indicates that Cav1 KO mice are more susceptible to promoter treatment as evidenced by increased epidermal proliferation. Furthermore, primary keratinocytes isolated from Cav1 KO mice have a proliferative advantage over WT keratinocytes in both low- and high-calcium medium, conditions that promote proliferation and induce differentiation, respectively. Collectively, these data indicate that Cav1 functions to suppress proliferation in the epidermis, and loss of this function promotes the development of benign skin tumors.
authors: Department of Cancer Biology/Stem Cell Biology and Regenerative Medicine, Thomas Jefferson University Philadelphia, PA, USA.
authors: Casey
authors: C
authors: Trimmer
authors: Federica
authors: F
authors: Sotgia
authors: Michael P
authors: MP
authors: Lisanti
authors: Franco
authors: F
authors: Capozza
keywords: Cav1; caveolin; skin; skin cancer; two stage carcinogenesis
references: J Am Acad Dermatol. 1994 May;30(5 Pt 1):774-8
references: 8176018
references: J Biol Chem. 1996 Apr 19;271(16):9690-7
references: 8621645
references: FEBS Lett. 1998 Oct 9;436(3):403-10
references: 9801158
references: Nat Rev Cancer. 2004 Jan;4(1):23-35
references: 14681688
references: Am J Pathol. 2003 Jun;162(6):2029-39
references: 12759258
references: Mol Biol Cell. 2003 Mar;14(3):1027-42
references: 12631721
references: Mol Cancer. 2007 Jan 25;6:10
references: 17254359
references: Cancer Res. 1999 Nov 15;59(22):5719-23
references: 10582690
references: Carcinogenesis. 2005 Oct;26(10):1657-67
references: 15905207
references: FEBS Lett. 1998 Jun 16;429(3):330-6
references: 9662443
references: Nat Cell Biol. 2001 Apr;3(4):368-75
references: 11283610
references: J Biol Chem. 1996 Jan 5;271(1):568-73
references: 8550621
references: Oncogene. 2007 May 14;26(22):3227-39
references: 17496918
references: Methods Mol Biol. 2005;289:3-14
references: 15502164
references: IUBMB Life. 2000 Dec;50(6):361-4
references: 11327308
references: Am J Physiol Cell Physiol. 2005 Jun;288(6):C1317-31
references: 15689413
references: Am J Physiol Cell Physiol. 2005 Mar;288(3):C677-91
references: 15548572
references: FEBS Lett. 1999 Apr 9;448(2-3):221-30
references: 10218480
references: Am J Pathol. 2006 Nov;169(5):1784-801
references: 17071600
references: N Engl J Med. 2001 Mar 29;344(13):975-83
references: 11274625
references: Cancer Res. 1995 Mar 15;55(6):1347-50
references: 7882334
references: Asian Pac J Cancer Prev. 2012;13(1):371-5
references: 22502704
references: J Biol Chem. 1996 May 17;271(20):11930-5
references: 8662667
references: Carcinogenesis. 1993 Nov;14(11):2353-8
references: 8242866
references: Physiol Rev. 2004 Oct;84(4):1341-79
references: 15383654
references: Br J Dermatol. 2002 Oct;147(4):701-9
references: 12366416
references: Am J Pathol. 2002 Oct;161(4):1357-69
references: 12368209
references: FEBS Lett. 1998 May 29;428(3):205-11
references: 9654135
references: Cancer Res. 2002 Mar 15;62(6):1641-7
references: 11912134
references: Carcinogenesis. 2004 Sep;25(9):1771-8
references: 15105299
references: Nat Protoc. 2009;4(9):1350-62
references: 19713956
references: J Biol Chem. 2001 Oct 12;276(41):38121-38
references: 11457855
references: Cancer Res. 2010 Oct 1;70(19):7489-99
references: 20709760
references: Cancer Res. 2001 Mar 15;61(6):2361-4
references: 11289096
references: J Invest Dermatol. 2009 Apr;129(4):927-36
references: 19005485
references: Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
references: 21372320
references: J Clin Invest. 2004 Sep;114(5):720-8
references: 15343391
references: Cancer Res. 2010 May 15;70(10):4222-32
references: 20406988
references: J Clin Oncol. 2005 Feb 1;23(4):759-65
references: 15681519
references: Cancer Res. 2001 May 15;61(10):3882-5
references: 11358800
references: J Cell Biol. 2007 Oct 22;179(2):341-56
references: 17938246
references: Nat Protoc. 2008;3(5):799-810
references: 18451788
references: J Biol Chem. 1999 Sep 3;274(36):25708-17
references: 10464308
references: Arch Dermatol. 1997 Jun;133(6):735-40
references: 9197827
references: J Biophys Biochem Cytol. 1955 Sep 25;1(5):445-58
references: 13263332
references: EMBO J. 1998 Nov 16;17(22):6633-48
references: 9822607
references: J Biol Chem. 1999 Sep 3;274(36):25718-25
references: 10464309
references: Am J Physiol Cell Physiol. 2003 Feb;284(2):C457-74
references: 12388077
references: J Biol Chem. 1997 Nov 14;272(46):29337-46
references: 9361015
references: Pharmacol Rev. 2002 Sep;54(3):431-67
references: 12223531
references: Arch Dermatol. 2010 Mar;146(3):283-7
references: 20231499
references: J Biol Chem. 1996 Jan 26;271(4):2255-61
references: 8567687
references: J Am Acad Dermatol. 2006 Sep;55(3):490-500
references: 16908356
references: J Biol Chem. 1999 Oct 22;274(43):30636-43
references: 10521449
references: Trends Cell Biol. 1994 Jul;4(7):231-5
references: 14731661